GLP-1s and Birth Control A GLP-1 receptor agonist may reduce the effectiveness of oral contraceptives
Subscribe to the daily blog at ConscienHealth ( an organization that works with experts and other groups to promote evidence-based approaches to health and obesity and serve as a voice for individuals affected by obesity
Knowing what safe, properly manufactured peptides should look like, how they should be stored, and what documentation should accompany them helps you identify red flags when evaluating potential suppliers
Technique tips: Rotate injection sites with each dose to prevent tissue irritation Always clean the injection site thoroughly with an alcohol swab before administering Pinch the skin slightly when injecting into the abdomen for comfort How to Store Improper storage degrades the peptide and reduces effectiveness
Adjust your diabetes medications if needed
For obesity management, NICE technology appraisal TA875 recommends semaglutide (Wegovy) only within specialist weight management services, for people with a BMI of at least 35 kg/m (or 30 kg/m with weight-related comorbidities) and as part of a programme including diet and physical activity for a maximum of 2 years
